سعر توريزيل Torisel 30مجم/1.2مل فيال 2026
Torisel 30mg/1.2ml i.v vialدواعي استعمال توريزيل
- علاج سرطان الخلايا الكلوية المتقدم.DailyMed (U.S. National Library of Medicine)
- Treatment of advanced renal cell carcinoma.DailyMed (U.S. National Library of Medicine)
معلومات الدواء
التفاصيل الكاملةالآثار الجانبيةSide effects
- Most common adverse reactions (>=30%): rash, asthenia, mucositis, nausea, edema and anorexia; common laboratory abnormalities include anemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, lymphopenia, thrombocytopenia, elevated creatinine and AST.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Most common adverse reactions (>=30%): rash, asthenia, mucositis, nausea, edema and anorexia; common laboratory abnormalities include anemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, lymphopenia, thrombocytopenia, elevated creatinine and AST.International label, same product · DailyMed (U.S. National Library of Medicine)
موانع الاستعمالContraindications
- Bilirubin >1.5x upper limit of normal.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Bilirubin >1.5x upper limit of normal.International label, same product · DailyMed (U.S. National Library of Medicine)
تحذيرات واحتياطاتWarnings & precautions
- Hypersensitivity/infusion reactions including anaphylaxis; monitor during infusion; caution with hypersensitivity to temsirolimus, sirolimus or polysorbate 80.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Hyperglycemia/glucose intolerance; test serum glucose before and during treatment.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Immunosuppression and infections including fatal Pneumocystis jiroveci pneumonia.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Hypersensitivity/infusion reactions including anaphylaxis; monitor during infusion; caution with hypersensitivity to temsirolimus, sirolimus or polysorbate 80.International label, same product · DailyMed (U.S. National Library of Medicine)
- Hyperglycemia/glucose intolerance; test serum glucose before and during treatment.International label, same product · DailyMed (U.S. National Library of Medicine)
- Immunosuppression and infections including fatal Pneumocystis jiroveci pneumonia.International label, same product · DailyMed (U.S. National Library of Medicine)
التداخلات الدوائيةDrug interactions
- Strong CYP3A4 inhibitors (e.g., ketoconazole)Sirolimus (active metabolite) AUC increased 3.1-fold and Cmax 2.2-fold; consider dose adjustment if alternative cannot be used.DailyMed (U.S. National Library of Medicine)
- Strong CYP3A4 inducers (e.g., rifampin)Sirolimus Cmax decreased 65% and AUC 56%; consider dose adjustment if alternative cannot be used.DailyMed (U.S. National Library of Medicine)
- Strong CYP3A4 inhibitors (e.g., ketoconazole)Sirolimus (active metabolite) AUC increased 3.1-fold and Cmax 2.2-fold; consider dose adjustment if alternative cannot be used.DailyMed (U.S. National Library of Medicine)
- Strong CYP3A4 inducers (e.g., rifampin)Sirolimus Cmax decreased 65% and AUC 56%; consider dose adjustment if alternative cannot be used.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعةPregnancy & breastfeeding
- Based on animal studies and mechanism of action, temsirolimus can cause fetal harm; no human data on Torisel in pregnancy.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Do not breastfeed during treatment and for 3 weeks after the final dose.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
- Based on animal studies and mechanism of action, temsirolimus can cause fetal harm; no human data on Torisel in pregnancy.International label, same product · DailyMed (U.S. National Library of Medicine)
- Do not breastfeed during treatment and for 3 weeks after the final dose.International label, same product · DailyMed (U.S. National Library of Medicine)
كيف يعمل الدواءHow it works
- Binds FKBP-12; the complex inhibits mTOR activity, interfering with synthesis of proteins regulating proliferation, growth and survival of tumour cells (US Torisel label).مثبط لإنزيم mTOR
- Temsirolimus: Binds FKBP-12; the complex inhibits mTOR activity, interfering with synthesis of proteins regulating proliferation, growth and survival of tumour cells (US Torisel label).
تابع أسعار الأدوية أول بأول
بننشر كل يوم أسعار أدوية اتغيرت والبدائل الأرخص
المعرّفات
- تصنيف ATC
- مراجع علمية للمادة الفعالة
- TemsirolimusPubChem (يفتح في نافذة جديدة)
أدوية ذات صلة
من فئة مضاد للأورام
- ابيفيمي 400مجم/16مل فيال للحقنمركز لمحلول للتسريب الوريدي17,081ج.م
- ابيفيمي 100مجم/4مل فيال للحقنمركز لمحلول للتسريب4,940ج.م
- ابيفيمي 400مجم/16مل فيال للحقنمركز لمحلول للتسريب الوريدي17,081ج.م
- ابراكسان 100مجم فيالمسحوق لمعلق للحقن (فيال)13,280ج.م
- ادسيتريس 50مجم محلول وريدبودرة لتحضير مركز محلول للتسريب69,296ج.م
- ADRIBLASTINA R.D 10MG VIAL. (N/A)مسحوق لمحلول للحقن (فيال)57ج.م
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- DailyMed (U.S. National Library of Medicine)
- WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)
- PubChem (NCBI)
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا